Here’s what drives us:
37 Million
people living with HIV/AIDS worldwide (1.8 million children).
18 Million
new cancer cases in 2018 with 9.5 million deaths worldwide.
$350,000+
Is the cost of a CAR-T cell therapy for Lymphoma, not including hospital costs.
Potentially life-saving advanced therapies are available, but they are neither affordable nor accessible to millions of patients.
Access to life-saving advanced therapies should be a human right for all in need, not just for the privileged few.
Here’s how we do it:
Safe, effective, accessible advanced therapies.
We develop improved advanced medicines that are manufactured affordably at hospitals to where patients come for care.
Strategic collaboration.
We’re working directly with a diverse array of stakeholders that support our vision of affordable access to advanced medicines worldwide.
Improving health equity.
We won’t stop until our curative cell-based gene therapies are accessible to everybody.
Every person should be able to access affordable advanced medicines.
Here’s how you can help:
Partner with us.
Help us develop improved advanced therapies and increase their affordability and access for the patients that need them.
Spread the word.
Follow and share our content on your social media channels.
